Global Hemoglobinopathies Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Hemoglobinopathies Market Research Report 2024
Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
According to MRAResearch’s new survey, global Hemoglobinopathies market is projected to reach US$ 384.7 million in 2033, increasing from US$ 274.5 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemoglobinopathies market research.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hemoglobinopathies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation
Segment by Type
Blood Transfusion
Iron Chelation Therapy
Bone Marrow Transplant
Others
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemoglobinopathies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Hemoglobinopathies market is projected to reach US$ 384.7 million in 2033, increasing from US$ 274.5 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemoglobinopathies market research.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hemoglobinopathies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation
Segment by Type
Blood Transfusion
Iron Chelation Therapy
Bone Marrow Transplant
Others
Segment by Application
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemoglobinopathies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source